Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

November 7, 2024

Study Completion Date

June 12, 2025

Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC)
Interventions
RADIATION

Adjuvant hypofractionation

15 fractions of 2.7 Gy per fraction daily over 3 weeks for a total of 40.5 Gy to the post-operative bed and/or necks.

RADIATION

Definitive Hypofractionation

15 fractions of 3 Gy per fraction daily over 3 weeks for a total of 45 Gy to regions of gross disease. Elective areas can be treated to 37.5 Gy in 15 fractions.

Trial Locations (4)

10003

Mount Sinai Downtown Union Square, New York

10011

Mount Sinai Chelsea, New York

10019

Mount Sinai West, New York

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04284540 - Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter